These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 9177688)
1. Method for the collection and assay of volatile organic compounds in breath. Phillips M Anal Biochem; 1997 May; 247(2):272-8. PubMed ID: 9177688 [TBL] [Abstract][Full Text] [Related]
2. Volatile biomarkers of pulmonary tuberculosis in the breath. Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588 [TBL] [Abstract][Full Text] [Related]
3. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath. Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018 [TBL] [Abstract][Full Text] [Related]
4. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath. Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903 [TBL] [Abstract][Full Text] [Related]
5. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642 [TBL] [Abstract][Full Text] [Related]
6. Metabolic and environmental origins of volatile organic compounds in breath. Phillips M; Greenberg J; Awad J J Clin Pathol; 1994 Nov; 47(11):1052-3. PubMed ID: 7829686 [TBL] [Abstract][Full Text] [Related]
7. Elimination kinetics of volatile organics in humans using breath measurements. Pellizzari ED; Wallace LA; Gordon SM J Expo Anal Environ Epidemiol; 1992; 2(3):341-55. PubMed ID: 1422163 [TBL] [Abstract][Full Text] [Related]
8. A profile of volatile organic compounds in breath discriminates COPD patients from controls. Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520 [TBL] [Abstract][Full Text] [Related]
9. Pilot study of a breath test for volatile organic compounds associated with oral malodor: evidence for the role of oxidative stress. Phillips M; Cataneo RN; Greenberg J; Munawar M; Nachnani S; Samtani S Oral Dis; 2005; 11 Suppl 1():32-4. PubMed ID: 15752095 [TBL] [Abstract][Full Text] [Related]
10. Elimination of volatile organic compounds in breath after exposure to occupational and environmental microenvironments. Raymer JH; Pellizzari ED; Thomas KW; Cooper SD J Expo Anal Environ Epidemiol; 1991 Oct; 1(4):439-51. PubMed ID: 1824328 [TBL] [Abstract][Full Text] [Related]
11. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
12. Do endogenous volatile organic chemicals measured in breath reflect and maintain CYP2E1 levels in vivo? Mathews JM; Raymer JH; Etheridge AS; Velez GR; Bucher JR Toxicol Appl Pharmacol; 1997 Oct; 146(2):255-60. PubMed ID: 9344893 [TBL] [Abstract][Full Text] [Related]
13. Breath analysis by mass spectrometry: a new tool for breast cancer detection? Patterson SG; Bayer CW; Hendry RJ; Sellers N; Lee KS; Vidakovic B; Mizaikoff B; Gabram-Mendola SG Am Surg; 2011 Jun; 77(6):747-51. PubMed ID: 21679645 [TBL] [Abstract][Full Text] [Related]
14. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air. Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363 [TBL] [Abstract][Full Text] [Related]
15. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760 [TBL] [Abstract][Full Text] [Related]
16. Optimization of sampling parameters for collection and preconcentration of alveolar air by needle traps. Filipiak W; Filipiak A; Ager C; Wiesenhofer H; Amann A J Breath Res; 2012 Jun; 6(2):027107. PubMed ID: 22621839 [TBL] [Abstract][Full Text] [Related]
17. Development of a multibed sorption trap, comprehensive two-dimensional gas chromatography, and time-of-flight mass spectrometry system for the analysis of volatile organic compounds in human breath. Sanchez JM; Sacks RD Anal Chem; 2006 May; 78(9):3046-54. PubMed ID: 16642992 [TBL] [Abstract][Full Text] [Related]
18. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492 [TBL] [Abstract][Full Text] [Related]
19. Ion-trap detection of volatile organic compounds in alveolar breath. Phillips M; Greenberg J Clin Chem; 1992 Jan; 38(1):60-5. PubMed ID: 1733607 [TBL] [Abstract][Full Text] [Related]
20. Variation in volatile organic compounds in the breath of normal humans. Phillips M; Herrera J; Krishnan S; Zain M; Greenberg J; Cataneo RN J Chromatogr B Biomed Sci Appl; 1999 Jun; 729(1-2):75-88. PubMed ID: 10410929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]